ERUM FAROOQI: Open Payments
NPI 1235391533 · BRASELTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 40 payments from 17 companies in 2025. Trend: 2023 $1,122 · 2024 $996 · 2025 $729
Food & beverage: $729
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $221 |
| SHIELD THERAPEUTICS INC | 3 | $68 |
| Abbott Laboratories | 3 | $67 |
| Lilly USA, LLC | 3 | $64 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $59 |
| PFIZER INC. | 3 | $47 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: Ozempic, Wegovy, ACCRUFER, FREESTYLE LIBRE 3, MOUNJARO, JOURNAVX, PREVNAR 20, Rybelsus.
Industry payments across GA — which companies pay providers there.
